Filter Results:
(628)
Show Results For
- All HBS Web
(1,051)
- People (3)
- News (261)
- Research (628)
- Events (1)
- Multimedia (6)
- Faculty Publications (295)
Show Results For
- All HBS Web
(1,051)
- People (3)
- News (261)
- Research (628)
- Events (1)
- Multimedia (6)
- Faculty Publications (295)
Sort by
- 15 Jun 2004
- Conference Presentation
What is the Best Measure of Adiposity for Predicting Testosterone? Results from the Massachusetts Male Aging Study
By: William B. Simpson, Frances J. Hayes, Andre B. Araujo and John B. McKinlay
Keywords: Measurement and Metrics; Health Testing and Trials; Age Characteristics; Gender Characteristics; Massachusetts
Simpson, William B., Frances J. Hayes, Andre B. Araujo, and John B. McKinlay. "What is the Best Measure of Adiposity for Predicting Testosterone? Results from the Massachusetts Male Aging Study." Paper presented at the Enocrine Society Annual Meeting, New Orleans, LA, June 15, 2004.
- 26 Nov 2001
- Research & Ideas
How Toyota Turns Workers Into Problem Solvers
consider what the Toyota people are attempting to accomplish. They are saying before you (or you all) do work, make clear what you expect to happen (by specifying the design), each time you do work, see that what you expected has actually occurred (by View Details
- 19 Sep 2016
- Research & Ideas
Why Isn't Business Research More Relevant to Business Practitioners?
presented their research on occupational safety to managers at the Occupational Safety and Health Administration, “both they and we learned a lot.” View Details
- 14 Jun 2010
- Research & Ideas
The Hard Work of Measuring Social Impact
requires greater access to education, health care, and employment resources; at the same time, you might be trying to influence public policy on issues that affect the homeless. That involves a whole set of... View Details
Keywords: by Julia Hanna
- 18 Jun 2018
- Research & Ideas
Warning: Scary Warning Labels Work!
sufficiently graphic don’t work. “San Francisco policymakers are devoting lots of time and money to fighting it out in court, and they’re operating on the assumption that text warning labels are going to... View Details
- September 1991 (Revised August 1994)
- Background Note
Note on Pharmaceutical Industry Regulation
Traces the evolution of U.S. regulatory policy towards the pharmaceutical industry over the course of the twentieth century. A major theme is the steady shift away from a policy of 'let the buyer beware' to the creation of a complex and time-consuming review process,... View Details
Keywords: Safety; Industry Growth; Marketing; Research and Development; Health Testing and Trials; Economics; Pharmaceutical Industry; United States
Emmons, Willis M., III. "Note on Pharmaceutical Industry Regulation." Harvard Business School Background Note 792-002, September 1991. (Revised August 1994.)
- 13 Oct 2009
- Research & Ideas
7 Lessons for Navigating the Storm
help leaders learn about leading through a crisis. There they will develop much faster than they will in leading through good times, or studying how other leaders behaved in crises. As the military learned long ago, there is simply no substitute for being in the thick... View Details
Keywords: by Martha Lagace
- 17 Nov 2003
- Research & Ideas
The Business Case for Diabetes Disease Management
analyze the complexities of disease management and check all avenues for potential business opportunities. The participants, almost all of them health professionals, sorted through the risks View Details
- December 2023 (Revised March 2024)
- Case
Manufacturing Moderna's Future
By: Satish Tadikonda and William Marks
In 2019, Moderna faced long odds of survival having failed to develop a successful clinical program out of the vast platform technology they had built around mRNA. Nearly overnight, the company skyrocketed to success with a vaccine for COVID-19, leading to an extremely... View Details
Keywords: Health Pandemics; Health Testing and Trials; Technological Innovation; Product Development; Production; Science-Based Business; Biotechnology Industry
Tadikonda, Satish, and William Marks. "Manufacturing Moderna's Future." Harvard Business School Case 824-076, December 2023. (Revised March 2024.)
- October 2020
- Teaching Plan
Merck: COVID-19 Vaccines
By: Willy C. Shih
COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,... View Details
- 2009
- Case
Innovamedica: Innovation in an Emerging Market
By: Roberto Charvel, Fernando Fabre and T. Putimahtama
Innovamedica was a medical start up with several state of the art devices such as a silicon substitute heart and other inventions. However, the founding scientist was struggling in attracting talent and fundraising and that had an impact on growth. View Details
Keywords: Biotech; Entrepreneurial Finance; Entrepreneurship; Start-up; Emergent Countries; Business Startups; Talent and Talent Management; Design; Corporate Entrepreneurship; Private Equity; Health Testing and Trials; Innovation and Invention; Managerial Roles; Biotechnology Industry; Latin America; North and Central America
Charvel, Roberto, Fernando Fabre, and T. Putimahtama. "Innovamedica: Innovation in an Emerging Market." Instituto Panamericano de Alta Dirección de Empresa (IPADE) Case (P)DGe-440, 2009.
- November 2003 (Revised September 2008)
- Case
Circle Gastroenterology Products (A)
By: Regina E. Herzlinger and James Weber
A new, minimally invasive medical device has achieved only one-third of its budget. Was the problem one of marketing strategy, sales, reimbursement, and/or clinical trials? View Details
Keywords: Health Testing and Trials; Marketing Strategy; Product Marketing; Sales; Medical Devices and Supplies Industry
Herzlinger, Regina E., and James Weber. "Circle Gastroenterology Products (A)." Harvard Business School Case 304-052, November 2003. (Revised September 2008.)
- 13 Feb 2013
- Research & Ideas
5 Weight Loss Tips From Behavioral Economists
Weight Loss: A Randomized, Controlled Trial," published in the June 2011 edition of Journal of General Internal Medicine. TIP #3- Fill your backpack with rocks. A research team from Harvard and the University of Central Florida View Details
Keywords: by Carmen Nobel
- February 2020
- Supplement
Theranos: Who Has Blood on Their Hands? (B)
By: Nien-he Hsieh, Christina R. Wing and John Masko
This supplemental case tracks the results of the Colman and Taubman-Dye class action suit against Theranos as well as Theranos’ other legal challenges and chronicles the final demise of the company in 2019. View Details
Keywords: Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Entrepreneurship; Lawsuits and Litigation; Business Exit or Shutdown; Medical Devices and Supplies Industry; California; United States
Hsieh, Nien-he, Christina R. Wing, and John Masko. "Theranos: Who Has Blood on Their Hands? (B)." Harvard Business School Supplement 320-091, February 2020.
- 1996
- Chapter
The Determinants of Research Productivity in Ethical Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
- 28 Nov 2011
- Research & Ideas
Rethinking the Fairness of Organ Transplants
distribution of recipients across different groups by age, race, diagnosis, and blood type. "This gives policymakers the ability to focus on what's important and relevant," he adds. "Right... View Details
- 14 Dec 2020
- Research & Ideas
What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?
aspects of the drug trial and approval process, including allowing time for potential issues to materialize. When you see an FDA emergency approval for a COVID-19 vaccine, don't interpret this as a normal... View Details
- 09 Mar 2015
- Research & Ideas
Why Entrepreneurs Should Go Work for Government
"private-public entrepreneurs" who establish private businesses that sell to government agencies or sometimes to citizens directly. In Philadelphia, for example, Textizen enables citizens to communicate with city health View Details
Keywords: by Michael Blanding
- June 2004 (Revised November 2004)
- Case
Acorda Therapeutics: Rebuilding the Spinal Cord
Acorda is an early-stage life science start-up with a promising product that is close to reaching the market (Phase III clinical trials). The company is grappling with how to expand its portfolio of molecules to make the business more sustainable. It faces classic... View Details
Keywords: Decision Making; Science-Based Business; Health Testing and Trials; Business Startups; Product Development; Biotechnology Industry
Enriquez-Cabot, Juan, Jonathan West, Marina Kolesnik, and Fiona Murray. "Acorda Therapeutics: Rebuilding the Spinal Cord." Harvard Business School Case 604-014, June 2004. (Revised November 2004.)
- 17 Nov 2003
- Research & Ideas
The Business of Babies
Chinese babies), and international restrictions and legislation concerning adoption. High-tech measures include IVF, artificial insemination, surrogacy, gamete interfallopian transfer (GIFT) in which the... View Details